Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C

Advanced or metastatic disease is common in both oesophagogastric and colorectal cancers, with poor 5-year survival despite palliative chemotherapy. We have investigated the sensitivity of gastrointestinal tumours to gemcitabine in combination with mitomycin C (GeM), using a modified ex vivo ATP-bas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Whitehouse, P A, Mercer, S J, Knight, L A, Di Nicolantonio, F, O'Callaghan, A, Cree, I A
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2003
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2395279/
https://ncbi.nlm.nih.gov/pubmed/14676810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601403
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados